Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Anticancer Res ; 42(12): 5743-5750, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-36456148

RESUMEN

BACKGROUND/AIM: We aimed to explore the role of intracellular C3 in pancreatic ductal adenocarcinoma (PDAC). MATERIALS AND METHODS: We evaluated C3 expression in PDAC using a gene expression database and tissue microarray. To clarify the role of C3 expression in PDAC, we conducted knockdown experiments using C3 short hairpin RNA (shRNA) in BxPC-3 cells. Differences in protein expression and cell behaviours were analysed. RESULTS: C3 was highly expressed in PDAC and correlated with cancer metastasis. In vitro experiments using BxPX-3 cells showed that C3 and its active form, C3a, were expressed in tumour cells. C3 knockdown reduced cell migration and invasion by inhibiting Akt/Smad pathway activation. TNF-α, not IL-6, enhanced C3 expression in this PDAC cell line. CONCLUSION: Intracellular C3 may regulate epithelial-mesenchymal transition in pancreatic cancer.


Asunto(s)
Carcinoma Ductal Pancreático , Complemento C3 , Transición Epitelial-Mesenquimal , Neoplasias Pancreáticas , Humanos , Carcinoma Ductal Pancreático/genética , Páncreas , Neoplasias Pancreáticas/genética , Proteínas Proto-Oncogénicas c-akt/genética , ARN Interferente Pequeño , Complemento C3/genética , Proteínas Smad , Línea Celular Tumoral , Neoplasias Pancreáticas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...